Term Name: | (1S,2S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol |
---|---|
Synonyms: | (1S,2S)-2-hexadecanoylamino-3-morpholino-1-phenylpropan-1-ol, (1S,2S)-3-morpholino-2-palmitoylamino-1-phenylpropan-1-ol, (1S,2S)-PPMP, (1S,threo)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, (1S,threo)-PPMP, (S,S)-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, (S,S)-PPMP, L-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol, L-threo-PPMP, N-[(1S,2S)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide, N-[(1S,2S)-1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]palmitamide, N-[(1S,2S)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]hexadecanamide, N-[(1S,2S)-2-hydroxy-1-(4-morpholinylmethyl)-2-phenylethyl]palmitamide |
Definition: | An N-[1-hydroxy-3-(morpholin-4-yl)-1-phenylpropan-2-yl]hexadecanamide in which both stereocentres have S configuration. |
Ontology: | ChEBI [CHEBI:75131] ( EBI ) |